BioSpace News Archive

Business

ICU Medical, Inc. Announces First Quarter 2021 Results

ICU Medical, Inc., a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, announced financial results for the quarter ended March 31, 2021.

May 6, 2021
·
12 min read
Deals

Xtant Medical Announces $20 Million Debt Financing with MidCap Financial

Xtant Medical Holdings, Inc., a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that the Company and its subsidiaries have entered into credit agreements with MidCap Financial Trust.

May 6, 2021
·
4 min read
Business

Viridian Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Updates

Viridian Therapeutics, Inc., a biopharmaceutical company advancing new treatments for patients suffering from serious diseases but underserved by current therapies, announced financial results for the first quarter of 2021 and provided corporate updates.

May 6, 2021
·
8 min read
Business

Celldex Reports First Quarter 2021 Financial Results and Provides Corporate Update

Celldex Therapeutics, Inc.Celldex Therapeutics, Inc.Celldex Therapeutics, Inc.Celldex Therapeutics, Inc. reported financial results for the first quarter ended March 31, 2021 and provided a corporate update.

May 6, 2021
·
12 min read
Business

Recro Reports First Quarter 2021 Financial Results

Recro Pharma, Inc., a dedicated contract development and manufacturing organization solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, reported financial results for the first quarter ended March 31, 2021.

May 6, 2021
·
18 min read
Biotech Bay

CRISPR Therapeutics and Nkarta Announce Global Collaboration to Develop Gene-Edited Cell Therapies for Cancer

Collaboration brings together breakthrough gene editing technology and leading natural killer (NK) cell and T cell discovery, development, and manufacturing capabilities

May 6, 2021
·
11 min read
Business

Misonix Reports Fiscal 2021 Third Quarter Financial ResultsMisonix Raises Guidance for neXus® Ultrasonic Surgical System to 200 Unit Placements by Fiscal 2021 Year-End

Misonix, Inc., a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, reported financial results for the fiscal 2021 third quarter ended March 31, 2021

May 6, 2021
·
15 min read
Ascendis Pharma A/S Announces Presentations for TransCon™ PTH at Upcoming Medical Conferences

Ascendis Pharma A/S announced presentations featuring TransCon PTH at two upcoming medical conferences: the 48th annual meeting of the European Calcified Tissue Society, taking place virtually May 6-8, 2021 and the 23rd European Congress of Endocrinology taking place virtually May 22-26, 2021.

May 6, 2021
·
6 min read
Pharm Country

Cara Therapeutics to Present at the BofA Securities 2021 Virtual Health Care Conference

Cara Therapeutics, Inc. announced that Derek Chalmers, Ph.D., D.Sc., President and Chief Executive Officer, will participate in a fireside chat at the BofA Securities 2021 Virtual Health Care Conference on Thursday, May 13, 2021 at 11:00 a.m. ET.

May 6, 2021
·
2 min read
Business

SIGA Reports Financial Results for Three Months Ended March 31, 2021

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, reported financial results for the three months ended March 31, 2021.

May 6, 2021
·
10 min read